Heitmann, J. S., Schlenk, R. F., Walz, J. S., Jung, S., Bitzer, M., Missios, P., Hartkopf, A. D., Deinzer, C. K., Ochsenreither, S., Pinzon, S. S. L. R., Pflügler, M., Jung, G., Salih, H. R. (2026). A phase I trial evaluating an optimized B7-H3xCD3 T cell engager for treatment of solid cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2667